Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States

Prior studies have shown reduced development of cardiac allograft vasculopathy (CAV) in multiorgan transplant recipients. The aim of this study was to compare the incidence of CAV between isolated heart transplants and simultaneous multiorgan heart transplants in the contemporary era. We utilized th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of heart and lung transplantation 2024-10, Vol.43 (10), p.1737-1746
Hauptverfasser: Shahandeh, Negeen, Kim, Juka S., Klomhaus, Alexandra M., Tehrani, David M., Hsu, Jeffrey J., Nsair, Ali, Khush, Kiran K., Fearon, William F., Parikh, Rushi V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1746
container_issue 10
container_start_page 1737
container_title The Journal of heart and lung transplantation
container_volume 43
creator Shahandeh, Negeen
Kim, Juka S.
Klomhaus, Alexandra M.
Tehrani, David M.
Hsu, Jeffrey J.
Nsair, Ali
Khush, Kiran K.
Fearon, William F.
Parikh, Rushi V.
description Prior studies have shown reduced development of cardiac allograft vasculopathy (CAV) in multiorgan transplant recipients. The aim of this study was to compare the incidence of CAV between isolated heart transplants and simultaneous multiorgan heart transplants in the contemporary era. We utilized the Scientific Registry of Transplant Recipients to perform a retrospective analysis of first-time adult heart transplant recipients between January 1, 2010 and December 31, 2019 in the United States. The primary end-point was the development of angiographic CAV within 5 years of follow-up. Among 20,591 patients included in the analysis, 1,279 (6%) underwent multiorgan heart transplantation (70% heart-kidney, 16% heart-liver, 13% heart-lung, and 1% triple-organ), and 19,312 (94%) were isolated heart transplant recipients. The average age was 53 years, and 74% were male. There were no significant between-group differences in cold ischemic time. The incidence of acute rejection during the first year after transplant was significantly lower in the multiorgan group (18% vs 33%, p 
doi_str_mv 10.1016/j.healun.2024.06.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3074726038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1053249824017066</els_id><sourcerecordid>3074726038</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-1f01037ee93fe1167f259d88f1bc93f5491125ad0ac0fee86e19665e5c6b51053</originalsourceid><addsrcrecordid>eNp9UU1v1TAQtBCIlsI_QMhHLgm2EzvJBQk98VGpEgfo2fKz131-cuxgO636P_jBOErhyGlXq5nZ3RmE3lLSUkLFh3N7AuXX0DLC-paIltD-GbqknA9NR-nwvPaEdw3rp_ECvcr5TAhhHWcv0UU3TpwIIS7R70OcF5VcjgFHi7VKximNlffxLilb8L3KevVxUeX0iF3QzkDQgI9QHgACzm5efVEB4prx1rqY7lTAKhhcRb0qYHA9NBVckgp58SoUnEC7xUEouUricgJ8G9yG_FEqIb9GL6zyGd481St0--Xzz8O35ub71-vDp5tGs56WhlpCSTcATJ0FSsVgGZ_MOFp61HXE-4lSxpUhShMLMAqgkxAcuBZHvnlzhd7vukuKv1bIRc4ua_B-_0d2ZOgHJkg3Vmi_Q3WKOSewckluVulRUiK3PORZ7nnILQ9JhKx5VNq7pw3rcQbzj_Q3gAr4uAOg_nnvIMms3eawcdWkIk10_9_wB6pVodo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3074726038</pqid></control><display><type>article</type><title>Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Shahandeh, Negeen ; Kim, Juka S. ; Klomhaus, Alexandra M. ; Tehrani, David M. ; Hsu, Jeffrey J. ; Nsair, Ali ; Khush, Kiran K. ; Fearon, William F. ; Parikh, Rushi V.</creator><creatorcontrib>Shahandeh, Negeen ; Kim, Juka S. ; Klomhaus, Alexandra M. ; Tehrani, David M. ; Hsu, Jeffrey J. ; Nsair, Ali ; Khush, Kiran K. ; Fearon, William F. ; Parikh, Rushi V.</creatorcontrib><description>Prior studies have shown reduced development of cardiac allograft vasculopathy (CAV) in multiorgan transplant recipients. The aim of this study was to compare the incidence of CAV between isolated heart transplants and simultaneous multiorgan heart transplants in the contemporary era. We utilized the Scientific Registry of Transplant Recipients to perform a retrospective analysis of first-time adult heart transplant recipients between January 1, 2010 and December 31, 2019 in the United States. The primary end-point was the development of angiographic CAV within 5 years of follow-up. Among 20,591 patients included in the analysis, 1,279 (6%) underwent multiorgan heart transplantation (70% heart-kidney, 16% heart-liver, 13% heart-lung, and 1% triple-organ), and 19,312 (94%) were isolated heart transplant recipients. The average age was 53 years, and 74% were male. There were no significant between-group differences in cold ischemic time. The incidence of acute rejection during the first year after transplant was significantly lower in the multiorgan group (18% vs 33%, p &lt; 0.01). The 5-year incidence of CAV was 33% in the isolated heart group and 27% in the multiorgan group (p &lt; 0.0001); differences in CAV incidence were seen as early as 1 year after transplant and persisted over time. In multivariable analysis, multiorgan heart transplant recipients had a significantly lower likelihood of CAV at 5 years (hazard ratio = 0.76, 95% confidence interval: 0.66-0.88, p &lt; 0.01). Simultaneous multiorgan heart transplantation is associated with a significantly lower long-term risk of angiographic CAV compared with isolated heart transplantation in the contemporary era.</description><identifier>ISSN: 1053-2498</identifier><identifier>ISSN: 1557-3117</identifier><identifier>EISSN: 1557-3117</identifier><identifier>DOI: 10.1016/j.healun.2024.06.014</identifier><identifier>PMID: 38950666</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>acute rejection ; Adult ; Allografts ; cardiac allograft vasculopathy ; coronary angiography ; Female ; Follow-Up Studies ; Graft Rejection - epidemiology ; heart transplantation ; Heart Transplantation - adverse effects ; Humans ; Incidence ; Male ; Middle Aged ; multiorgan transplantation ; Postoperative Complications - epidemiology ; Postoperative Complications - etiology ; Registries ; Retrospective Studies ; United States - epidemiology</subject><ispartof>The Journal of heart and lung transplantation, 2024-10, Vol.43 (10), p.1737-1746</ispartof><rights>2024 International Society for the Heart and Lung Transplantation</rights><rights>Copyright © 2024 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c241t-1f01037ee93fe1167f259d88f1bc93f5491125ad0ac0fee86e19665e5c6b51053</cites><orcidid>0000-0002-7811-8063</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1053249824017066$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38950666$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shahandeh, Negeen</creatorcontrib><creatorcontrib>Kim, Juka S.</creatorcontrib><creatorcontrib>Klomhaus, Alexandra M.</creatorcontrib><creatorcontrib>Tehrani, David M.</creatorcontrib><creatorcontrib>Hsu, Jeffrey J.</creatorcontrib><creatorcontrib>Nsair, Ali</creatorcontrib><creatorcontrib>Khush, Kiran K.</creatorcontrib><creatorcontrib>Fearon, William F.</creatorcontrib><creatorcontrib>Parikh, Rushi V.</creatorcontrib><title>Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States</title><title>The Journal of heart and lung transplantation</title><addtitle>J Heart Lung Transplant</addtitle><description>Prior studies have shown reduced development of cardiac allograft vasculopathy (CAV) in multiorgan transplant recipients. The aim of this study was to compare the incidence of CAV between isolated heart transplants and simultaneous multiorgan heart transplants in the contemporary era. We utilized the Scientific Registry of Transplant Recipients to perform a retrospective analysis of first-time adult heart transplant recipients between January 1, 2010 and December 31, 2019 in the United States. The primary end-point was the development of angiographic CAV within 5 years of follow-up. Among 20,591 patients included in the analysis, 1,279 (6%) underwent multiorgan heart transplantation (70% heart-kidney, 16% heart-liver, 13% heart-lung, and 1% triple-organ), and 19,312 (94%) were isolated heart transplant recipients. The average age was 53 years, and 74% were male. There were no significant between-group differences in cold ischemic time. The incidence of acute rejection during the first year after transplant was significantly lower in the multiorgan group (18% vs 33%, p &lt; 0.01). The 5-year incidence of CAV was 33% in the isolated heart group and 27% in the multiorgan group (p &lt; 0.0001); differences in CAV incidence were seen as early as 1 year after transplant and persisted over time. In multivariable analysis, multiorgan heart transplant recipients had a significantly lower likelihood of CAV at 5 years (hazard ratio = 0.76, 95% confidence interval: 0.66-0.88, p &lt; 0.01). Simultaneous multiorgan heart transplantation is associated with a significantly lower long-term risk of angiographic CAV compared with isolated heart transplantation in the contemporary era.</description><subject>acute rejection</subject><subject>Adult</subject><subject>Allografts</subject><subject>cardiac allograft vasculopathy</subject><subject>coronary angiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Graft Rejection - epidemiology</subject><subject>heart transplantation</subject><subject>Heart Transplantation - adverse effects</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Middle Aged</subject><subject>multiorgan transplantation</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - etiology</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>United States - epidemiology</subject><issn>1053-2498</issn><issn>1557-3117</issn><issn>1557-3117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1v1TAQtBCIlsI_QMhHLgm2EzvJBQk98VGpEgfo2fKz131-cuxgO636P_jBOErhyGlXq5nZ3RmE3lLSUkLFh3N7AuXX0DLC-paIltD-GbqknA9NR-nwvPaEdw3rp_ECvcr5TAhhHWcv0UU3TpwIIS7R70OcF5VcjgFHi7VKximNlffxLilb8L3KevVxUeX0iF3QzkDQgI9QHgACzm5efVEB4prx1rqY7lTAKhhcRb0qYHA9NBVckgp58SoUnEC7xUEouUricgJ8G9yG_FEqIb9GL6zyGd481St0--Xzz8O35ub71-vDp5tGs56WhlpCSTcATJ0FSsVgGZ_MOFp61HXE-4lSxpUhShMLMAqgkxAcuBZHvnlzhd7vukuKv1bIRc4ua_B-_0d2ZOgHJkg3Vmi_Q3WKOSewckluVulRUiK3PORZ7nnILQ9JhKx5VNq7pw3rcQbzj_Q3gAr4uAOg_nnvIMms3eawcdWkIk10_9_wB6pVodo</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Shahandeh, Negeen</creator><creator>Kim, Juka S.</creator><creator>Klomhaus, Alexandra M.</creator><creator>Tehrani, David M.</creator><creator>Hsu, Jeffrey J.</creator><creator>Nsair, Ali</creator><creator>Khush, Kiran K.</creator><creator>Fearon, William F.</creator><creator>Parikh, Rushi V.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7811-8063</orcidid></search><sort><creationdate>202410</creationdate><title>Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States</title><author>Shahandeh, Negeen ; Kim, Juka S. ; Klomhaus, Alexandra M. ; Tehrani, David M. ; Hsu, Jeffrey J. ; Nsair, Ali ; Khush, Kiran K. ; Fearon, William F. ; Parikh, Rushi V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-1f01037ee93fe1167f259d88f1bc93f5491125ad0ac0fee86e19665e5c6b51053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>acute rejection</topic><topic>Adult</topic><topic>Allografts</topic><topic>cardiac allograft vasculopathy</topic><topic>coronary angiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Graft Rejection - epidemiology</topic><topic>heart transplantation</topic><topic>Heart Transplantation - adverse effects</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Middle Aged</topic><topic>multiorgan transplantation</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - etiology</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shahandeh, Negeen</creatorcontrib><creatorcontrib>Kim, Juka S.</creatorcontrib><creatorcontrib>Klomhaus, Alexandra M.</creatorcontrib><creatorcontrib>Tehrani, David M.</creatorcontrib><creatorcontrib>Hsu, Jeffrey J.</creatorcontrib><creatorcontrib>Nsair, Ali</creatorcontrib><creatorcontrib>Khush, Kiran K.</creatorcontrib><creatorcontrib>Fearon, William F.</creatorcontrib><creatorcontrib>Parikh, Rushi V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of heart and lung transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shahandeh, Negeen</au><au>Kim, Juka S.</au><au>Klomhaus, Alexandra M.</au><au>Tehrani, David M.</au><au>Hsu, Jeffrey J.</au><au>Nsair, Ali</au><au>Khush, Kiran K.</au><au>Fearon, William F.</au><au>Parikh, Rushi V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States</atitle><jtitle>The Journal of heart and lung transplantation</jtitle><addtitle>J Heart Lung Transplant</addtitle><date>2024-10</date><risdate>2024</risdate><volume>43</volume><issue>10</issue><spage>1737</spage><epage>1746</epage><pages>1737-1746</pages><issn>1053-2498</issn><issn>1557-3117</issn><eissn>1557-3117</eissn><abstract>Prior studies have shown reduced development of cardiac allograft vasculopathy (CAV) in multiorgan transplant recipients. The aim of this study was to compare the incidence of CAV between isolated heart transplants and simultaneous multiorgan heart transplants in the contemporary era. We utilized the Scientific Registry of Transplant Recipients to perform a retrospective analysis of first-time adult heart transplant recipients between January 1, 2010 and December 31, 2019 in the United States. The primary end-point was the development of angiographic CAV within 5 years of follow-up. Among 20,591 patients included in the analysis, 1,279 (6%) underwent multiorgan heart transplantation (70% heart-kidney, 16% heart-liver, 13% heart-lung, and 1% triple-organ), and 19,312 (94%) were isolated heart transplant recipients. The average age was 53 years, and 74% were male. There were no significant between-group differences in cold ischemic time. The incidence of acute rejection during the first year after transplant was significantly lower in the multiorgan group (18% vs 33%, p &lt; 0.01). The 5-year incidence of CAV was 33% in the isolated heart group and 27% in the multiorgan group (p &lt; 0.0001); differences in CAV incidence were seen as early as 1 year after transplant and persisted over time. In multivariable analysis, multiorgan heart transplant recipients had a significantly lower likelihood of CAV at 5 years (hazard ratio = 0.76, 95% confidence interval: 0.66-0.88, p &lt; 0.01). Simultaneous multiorgan heart transplantation is associated with a significantly lower long-term risk of angiographic CAV compared with isolated heart transplantation in the contemporary era.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38950666</pmid><doi>10.1016/j.healun.2024.06.014</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-7811-8063</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1053-2498
ispartof The Journal of heart and lung transplantation, 2024-10, Vol.43 (10), p.1737-1746
issn 1053-2498
1557-3117
1557-3117
language eng
recordid cdi_proquest_miscellaneous_3074726038
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects acute rejection
Adult
Allografts
cardiac allograft vasculopathy
coronary angiography
Female
Follow-Up Studies
Graft Rejection - epidemiology
heart transplantation
Heart Transplantation - adverse effects
Humans
Incidence
Male
Middle Aged
multiorgan transplantation
Postoperative Complications - epidemiology
Postoperative Complications - etiology
Registries
Retrospective Studies
United States - epidemiology
title Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A11%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20cardiac%20allograft%20vasculopathy%20incidence%20between%20simultaneous%20multiorgan%20and%20isolated%20heart%20transplant%20recipients%20in%20the%20United%20States&rft.jtitle=The%20Journal%20of%20heart%20and%20lung%20transplantation&rft.au=Shahandeh,%20Negeen&rft.date=2024-10&rft.volume=43&rft.issue=10&rft.spage=1737&rft.epage=1746&rft.pages=1737-1746&rft.issn=1053-2498&rft.eissn=1557-3117&rft_id=info:doi/10.1016/j.healun.2024.06.014&rft_dat=%3Cproquest_cross%3E3074726038%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3074726038&rft_id=info:pmid/38950666&rft_els_id=S1053249824017066&rfr_iscdi=true